Head of School Report
Professor Nick Shaw - Head of School As you will see from the contents of the Newsletter, the School continues to be a busy and industrious place.

You will note with excitement, as we have done in the School, the continuing work on Pharmacy Australia Centre of Excellence (PACE). At the time of writing the project is running well and we have received a degree of media coverage regarding PACE in both local and national outlets.

PACE will be a terrific development for the School and will represent a new phase of growth and development for pharmacy teaching, research and scholarship within Queensland and Australia. You will note that our growth has already started, with the recruitment of a significant number of new staff across the School. We welcome them all and wish them all success. Research activities have continued to grow and develop within the School and we also welcome new researchers and new research students to the School. You will note more research news later in this Newsletter.

One of the other important themes of this issue of the Newsletter is the degree of international interaction in which the School is engaged – from contributions at international conferences to visits to the School from international delegates. As you will note later, Lisa Nissen and I visited Singapore and Malaysia in early March. Our visit was designed to enhance the School’s profile in Singapore and Malaysia and particularly in Kuala Lumpur. Many of the Colleges and Polytechnics we visited were keen to develop links with Pharmacy and recognised the quality of the programs delivered at UQ and the reputation of the School.

The new academic year has just started. This is always a really hectic time of year but it is great to see the enrolment of our new cohort of students into the Bachelor of Pharmacy program and to greet the return of years 2, 3 and 4.

Also commencing in the School are new postgraduate students undertaking research or coursework programs. To everyone I offer my best wishes for a successful and fulfilling year!

Professor Nick Shaw
Head of School

School Welcomes 2008 First Year Students

An Introductory Lecture was presented by the Head of School, Professor Nick Shaw on February 19th at the UQ Centre Lecture Theatre as part of Orientation Week.

The Lecture welcomed new students commencing this year in the Bachelor of Pharmacy degree at the School of Pharmacy.

The 2008 First Year group, comprising of 246 students, were introduced to Academic and Support Staff and led through a slide show that detailed them on many aspects of life at UQ and the School.

After the official lecture, students and staff were treated to a BBQ that was hosted by the Queensland Pharmacy Student's Association (QPSA), who also presented a talk on what the Association offers to Pharmacy Students.

The School of Pharmacy would like to extend a warm welcome to all new students commencing in 2008, and wish you all the best in your time with us here at UQ.


Premier Launches PACE Construction

The $120 million first stage of a new UQ centre will ease a chronic shortage of pharmacists and help to improve health care nationally and globally.

Queensland Premier Anna Bligh inspected the 1.7ha site of the Pharmacy Australia Centre of Excellence (PACE) on March 7, saying Queensland was about to realise a plan to lead the nation in bringing pharmacy education, research and industry together in one location.

"The University of Queensland will be the first cab off the rank with the relocation of its internationally-recognised School of Pharmacy to the precinct and a ramping up of its research into the Quality Use of Medicines," she said.

A first for the Asia-Pacific, PACE will combine Australia's leading pharmacy educators and researchers with key pharmacy professional organisations and commercial research and development groups.




UQ's Deputy Vice-Chancellor (International and Development), Professor Trevor Grigg, said the Queensland Government made PACE possible by donating the land - which adjoins the Princess Alexandra Hospital in Brisbane - in 2001. Construction follows an agreement between UQ and Alba Capital Partners.

“The location has risen in strategic importance since the Government donated the land. It is now part of what will become a concentrated health and pharmaceutical version of Silicon Valley.

“PACE will be a stone's throw from the planned Translational Research Institute, which will house UQ's Diamantina Institute for Cancer, Immunology and Metabolic Medicine and scientists from the Mater Medical Research Institute, Queensland University of Technology and the Princess Alexandra Hospital,” Professor Grigg said.

UQ's School of Pharmacy will move into Stage One, which is scheduled for completion in early 2010. In anticipation of PACE's extra capacity, UQ has increased new pharmacy student enrolments from 185 in 2006 to 246 in 2008. Numbers will continue growing in order to ease a widespread shortage of pharmacists that is estimated to reach 3000 nationally in 2010.

“Optimal health care requires multi-professional education as well as more graduates, and that is facilitated by co-locating education and research for health professionals in a centre such as this,” Professor Grigg said.

Michael Still, managing director of Alba, said the company is pleased to be working in partnership with UQ to provide Australia with an innovative and functional development that will set a global benchmark for medical research and education precincts.

“Alba is focused on a partnership approach as demonstrated by a history of successfully developed projects within the university sector,” he said.


PACE - Artist's Impression “PACE will be a state of the art pharmaceutical research, education and drug commercialisation precinct cementing Queensland's position at the forefront of medical research.”

PACE will complement and enhance UQ's established strengths in biotechnology, nanotechnology and molecular bioscience.

The researchers attracted to it will include top Australian and international postgraduate students who want to develop new and improved pharmaceuticals as well as better results for consumers.
Stage one will cover 10,155 square metres including lab space, a 360 seat lecture theatre, other teaching facilities, offices, and basement parking.

Subsequent stages are envisaged to include up to 30,000 square metres to accommodate entities involved in health and pharmaceutical research and development and services.

“This unique project will eventually cover every aspect of the pharmaceutical production line from drug discovery to eventual use, offering world class, coordinated and cost-effective research and testing capability,” Professor Grigg said.

Other confirmed PACE partners and future tenants include The Pharmaceutical Society of Australia, the Society of Hospital Pharmacists of Australia and the Australian Institute of Pharmacy Management.


Internationalisation Events Showcase The School of Pharmacy at UQ

During March, Head of School Professor Nick Shaw, and Dr Lisa Nissen travelled to Asia to attend multiple events, as well as make headway on discussions with key Asian Universities regarding a potential articulation arrangements with the University of Queensland.

Professor Shaw and Dr Nissen attended the IDP Singapore Health Expo on Saturday the 8th and Sunday the 9th of March to present their talk on the School of Pharmacy, "Pharmacy Education at its Best".

This talk was also presented at the Austrade Australian Education Showcase in Suntec City, Singapore, on the weekend of March 15th and 16th.

The trip also enabled Professor Shaw and Dr Nissen to visit with various Junior Colleges and Education Agents in Malaysia, as well as meeting with sponsors of Undergraduate and Postgraduate studies.

Discussions are also ongoing concerning the possibility of the School of Pharmacy working with IMU (International Medical University) in Kuala Lumpar, Malaysia, to establish a partnership between the two institutions. Discussions will progress further in mid to late 2008.


School of Pharmacy Offers Public Weekly Seminars 

The School of Pharmacy is again offering free weekly seminars for all interested attendees including academics, RHD candidates, researchers & any UQ staff who wish to attend.

The seminars run for 45 minutes each Wednesday at 1pm, and feature speakers who are leaders in their fields from across UQ as well as other institutes, both Queensland & Australia wide.

No RSVP is required for these events. More details are available here concerning specific seminar topics and speakers.
 


School of Pharmacy Academics Head APOP (Acute Post-Operative Pain) Project

The acute postoperative pain (APOP) project is a quality improvement initiative being undertaken in sixty-two public and private hospitals across Australia.
 
The APOP project aims to promote pain assessment, safe and effective prescribing of postoperative analgesics and effective communication of a pain management plan to patients and to general practitioners at discharge. In QLD 13 hospitals along with Darwin Hospital undertook the APOP project.
 
In consultation with anaesthetists, the Australian and New Zealand College of Anaesthetists (ANZCA) and Faculty of Pain Medicine, quality indicators were developed based on the Acute Pain Management: Scientific Evidence, second edition, 2005 and the Therapeutic Guidelines: Analgesic, Version 4, 2002.
 
APOP data collection commenced in October 2006 and was completed in February 2007. The educational intervention was carried out between April and June 2007. Follow-up data was collected from patients admitted from July 2007 – October 2007.

 
Key messages promoted during the education program:
  • Optimal postoperative pain management begins in the preoperative period
  • Measure pain regularly using a validated pain assessment tool
  • Ensure all postoperative patients receive safe and effective analgesia
  • Monitor and manage adverse events
  • Communicate ongoing pain management plan to both patients and primary healthcare professionals at discharge.
APOP successfully improved some practices with respect to pain management in QLD especially:
  • Documentation of preoperative education
  • Increased use of pain scores, as well as increased documentation at rest and movement
  • Increased documentation of sedation scores for patients receiving an opioid
  • Increased discharge communication to the patient and GP
Improvement was also seen when comparing documentation in the patient notes with what was reported by the patient. This was particularly notable with equal reporting and documentation of pain scores. Communication at discharge to the GP also increased as per the GP report, with more summaries being received in a timely manner, more summaries containing a plan, with clear direction and improvement in overall communication.
 
On Wednesday 16h January representatives from APOP hospitals in QLD met to wrap up the APOP project.

The School of Pharmacy team -   Lisa Pulver, Donna Taylor, Judith Coombes and Sue Tett are now looking forward to commencing their next national drug use evaluation project. Recruitment for 15 hospitals to participate in a project to improve discharge medication in acute coronary syndrome (DMACS) has already commenced.


School of Pharmacy Bursary for UQ Foundation Year Students

The School of Pharmacy at The University of Queensland is offering one bursary per year exclusively to UQ Foundation Year Students. The bursary will be awarded to an outstanding UQ Foundation Year graduate seeking admission into the Pharmacy degree at The University of Queensland.

The bursary is awarded on academic merit. The winner will be announced at the Foundation Year graduation ceremony in December.

Value
  • The Pharmacy Bursary is for AUD$3,000. A cheque post-dated to March 31 2009 (census date for Semester One enrolments) will be awarded to the successful students.
Eligibility
  • Applicants for the Pharmacy Bursary must be current UQ Foundation Year students.
  • The award is for students intending to enrol in the Pharmacy degree. The bursary is not transferable should the student decide to enrol in any other discipline.
  • The student must have studied the correct prerequisite subjects during the UQ Foundation Year to enrol in Pharmacy.

Selection Criteria

  • Applicants will be assessed on academic merit and reference (submitted by their nominated teacher).
  • Applicants must have a minimum IELTS of 7.
  • An interview may be required with members from The School of Pharmacy to assist with the selection process.

Application Procedures

 Students should complete the application form downloadable here and include:
  • A covering letter outlining why you wish to study Pharmacy at UQ.
  • A brief summary of extra-curricular activities and interests you believe are relevant to the short listing committee.
  • Submit these documents by email to scholarships@fdn.uq.edu.au
  • Request your nominated Foundation teacher to email an academic reference to scholarships@fdn.uq.edu.au
(IES will attach your confidential reference letter from your nominated teacher and Foundation results to your application).

Closing Date
 
Closing date for February 2009 intake is 7th November 2008.
For further information, or to download an application form, please visit the School of Pharmacy website.
  

Dr Christine Staatz Receives Lions Medical Research Foundation GrantDr Christine Staatz

Congratulations to Dr Christine Staatz - a Research Fellow within the School of Pharmacy - who has been awarded the highly competitive Lions Medical Research Foundation "Senior Medical Research Fellowship".

The three-year fellowship will enable Christine to further her research into anti-rejection medication for organ transplant recipients.

After organ transplantation, recipients need to take anti-rejection medications for the rest of their lives to stop their immune system from rejecting their new organ. The treatment with powerful drugs is vital for the long-term success of their transplant. Christine said too many people experienced transplant rejection, drug toxicity or infection due to poorly managed therapy. Her research project aims to improve the use of immunosuppressant drugs and eventually enhance the quality of life of Australian organ transplant recipients.

Christine’s Lions Fellowship Project will be carried out at the Princess Alexandra hospital and UQ. Christine works in close collaboration with the Faculty's Professor Susan Tett and Professor Stephen Lynch, Professor David Johnson and Mr Paul Taylor from the Princess Alexandra Hospital. The research work will be performed with assistance from a larger multi-disciplinary group, including transplant physicians, nurses, scientists, university academics, pharmacists and transplant coordinators.


Early Researchers Recognised in 2007 Pharmacy RHD Quality Awards

Each year the School of Pharmacy recognises its high achieving PhD candidates with 3 RHD Quality Awards. The awards for 2007 were announced at the Postgraduate Research Day held at the School on February 20th, 2008.

Congratulations go to the 3 winners whose research efforts were rewarded with the following prizes:


  • The prize for the highest quality research output by a research higher degree candidate in the area of Modeling and Simulation, is named after Professor Ted Triggs who was an early leader in the area of Pharmacokinetics with early key publications in the prestigious journal Nature. He also contributed greatly to the teaching of Pharmacy at UQ.

    This year the $1000 Professor Ted Triggs prize ($1000) goes to Michael Barras for his paper – “Individualized Compared with Conventional Dosing of Enoxaparin”, Published in the Clinical Pharmacology and Therapeutics journal.

    The role of pharmacokinetic modeling and simulation in assisting drug development is well recognized. However, few dose strategies have been evaluated against current therapy using a prospective, randomized design. This study demonstrated a significant reduction in bleeding for a common anticoagulant and was published in the highest ranking pharmacology journal.
 
  • The prize for the highest quality research output by a research higher degree candidate in the area of Therapeutic Targeting, is named after William Harris (1917-1989). He is remembered for his great intellect and his amazing recall of a wide spectrum of pharmaceutical science information, as well as for teaching many of the current leaders in pharmacy research.

    This year the $1000 William Harris Prize goes to Cho Aung for her paper “Plasma membrane Ca2+-ATPase expression during colon cancer cell line differentiation”, Published in the Biochemical and Biophysical Research Communications journal.

    BBRC is “the premier international journal devoted to the very rapid dissemination of … results in diverse fields”. Cho’s work has since been confirmed by an article published in Cell Calcium and the paper has been cited in Nature Reviews Cancer.
  
  • The prize for the highest quality research output by a research higher degree candidate in the area of Quality Use of Medicines is named after Professor Lloyd Sansom. He is a role model for many in the Pharmacy profession and has been a leader in Quality Use of Medicine across many professions. Professor Sansom was the inaugural Chair of the Australian Pharmaceutical Advisory Committee (APAC); he now Chairs the Pharmaceutical Benefits Advisory Committee (PBAC).

    This year the $1000 Prof Lloyd Sansom prize goes to Ian Coombes for his paper “Safe medication practice tutorials: a practical approach to preparing prescribers”, Published in The Clinical Teacher.

    This article describes a novel QUM intervention to improve the safety and quality of interns’ prescribing. It has been quoted in the journal’s editorial and in a forthcoming MJA article. The intervention has been implemented by The University of Queensland School of Medicine and has also been adopted by the National Prescribing Service.

 

 
Jia Yan See Awarded 2008 Foundation Year Bursary
Ms Jin Yan See receives Foundation Year Bursary
 
Ms Jia Yan See received the School of Pharmacy Foundation Year Bursary for 2008.

The $3000 scholarship recognises Jia's outstanding performance during her Foundation Year, which she completed during 2007.

Jia commenced her Bachelor of Pharmacy degree with the School in Semester One this year.

Many congratulations go to Jia on winning this highly competitive award, and we wish her the best of luck while completing her Bachelor of Pharmacy.

 
 
 
 
 
 
 

 
Helen Faddy Receives David Walsh Symposium Presentation Prize
 
Ms Helen Faddy
Several of the School's Research Higher Degree candidates and Honours candidates attended the Annual Combio meeting held at Darling Harbor in Sydney between the 22nd and 26th of September, 2007.
 
Combio represents one of the largest biological meetings in Australia and includes Biochemistry, Molecular Biology, Plant Scientists and Cell and Developmental Biology.
 
Helen Faddy, a final year PhD candidate, was awarded the David Walsh Symposium Presentation prize for her oral presentation, which was titled "Calcium transport in the mammary gland: a role for secretory pathway calcium ATPase 2 (SPCA2) in normal physiology and breast cancer".
 
Congratulations Helen on this outstanding achievement!
 
 
 

 

Pharmacy Shaves for a Cure

This year's "World's Greatest Shave" saw School of Pharmacy staff & students alike going under the razor or spray can to help raise funds for the Leukemia Foundation.

Participants and onlookers enjoyed a drink at the University's "Red Room" on March 17th, while the ladies from the Uni Hair Salon gave generously of their time to give some much enjoyed make-overs.

The School of Pharmacy would like to thank the Queensland Pharmacy Student's Association for all their effort in organising the event, which enabled staff and students to raise in excess of $1100 for the Leukemia Foundation.

Well done to all the brave ones who took it all off!

 
 
 

PhD Candidates Present at AAPS Conference, San Diego

 
In November, the School's Modelling and Simulation group of Dr Carl Kirkpatrick, Dr Bruce Green, Dr Glynn Morrish (post-doc), Ms Phey Yen Han, Mr Michael Barras, and Ms Sarah McLeay (PhD candidates) travelled to the US to present their recent work on obesity to Pfizer and at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition.
 
Sarah reports "We first travelled to the east coast to visit Pfizer in Connecticut, where we spent some time with the Clinical Pharmacology team on-site at Groton. This was an opportunity for us to present our work that is currently being carried out under a grant from Pfizer Global, and for them to present some of their interesting projects to us (albeit without them mentioning any specific drug details!). We then headed back to the west coast for the AAPS conference which was held from the 11th-15th November at the San Diego Convention Center, in sunny California. AAPS is one of the largest pharmaceutical conferences internationally, and over 13,000 people had registered to attend".
 
Due to the size of the conference there were many talks and round-table discussions applicable to the group’s research and as a result, they were kept very busy during their few days there. On the third day, Phey Yen, Michael, Glynn and Sarah each presented a poster, with Glynn selected as a featured presenter for a special poster podium session on translational pharmaceutical research.
 
Glynn’s work looked at predicting drug exposure from Caucasians to the Japanese population using lean body weight as a body composition metric.
 
Phey Yen’s poster explored the effect of study design and the importance of weight stratification in clinical trials to identify true differences in populations.
 
Michael presented results of his enoxaparin study which showed that an individualized dosing strategy based on lean body weight was superior to conventional dosing in reducing bleeding events whilst maintaining effectiveness, while Sarah presented work from a simulation study that explored the use of lean body weight instead of total body weight for predicting drug clearance in the obese population.
 
All posters were received very well, and the session was an excellent opportunity for the group to meet and interact with well-known researchers in the field.
 
As the modelling and simulation research community is quite small, their group relies on international conferences for presenting work, and AAPS provided an excellent opportunity for them to showcase some of the modelling and simulation research being conducted here in the School of Pharmacy and network with other researchers. The group were fortunate enough to have their work and travel funded by a grant from Pfizer Global R&D.
 

 
PhD Candidate Cho Sanda Aung Attends AACR Conference, Singapore
 
During November 2007, School of Pharmacy PhD candidate Cho Sanda Aung travelled to Singapore to attend an AACR conference, and presents her report on the event here: "I was given the opportunity to attend the American Association for Cancer Research (AACR) Centennial Conference held at Suntec International Convention and Exhibition Centre in Singapore from the 4th - 8th of November 2007.
 
To attend this international conference, I was supported by a travel grant from the school of pharmacy. This conference was entitled “Translational Cancer Medicine: Technologies to Treatment” and was jointly sponsored by the American Association for Cancer Research (AACR) and the Genome Institute of Singapore.
 
The main purpose of this conference was to exchange the expertise and technology between Asian countries and the AACR group, and to present and discuss new and developing technologies that will enable the translation of laboratory discoveries into new medicines for cancer.
 
The conference included both symposia and poster presentations. Presentations covered diverse topics that included cancer prevention, therapeutics, drug development, proteomics, genomics, biomarker discovery, clinical trials, and new technologies. I presented my work during the poster presentation section.
 
I received encouraging feedback from those attending the conference. Conference delegates shared their views and ideas and offered valuable suggestions regarding my project. This conference was very helpful in increasing my awareness of possible future advances in biotechnology and medicine. I also found the career workshops held during the conference very valuable.
 
Singapore is famous as a tourist destination, and I was able to do some sightseeing during my stay. I would like to thank the School of Pharmacy for their travel support, and my supervisors for their guidance throughout my study."
 

 
Professor Istvan Toth attends ICDDD 2008, Dubai
 
Professor Istvan Toth & Dr Pavla Simerska The 1st International Conference on Drug Design and Discovery (ICDDD) was held at the World Trade Centre, Dubai, UAE, February 4th to 7th, 2008.
 
The ICDDD 2008 was the first major international conference and exhibition of this series. The aim was to present cutting edge advances in various disciplines of drug design and discovery. Over 500 world’s leading scientific, industrial academic experts including several Nobel Laureates in medicine and clinical chemistry presented their findings.
 
It brought together chemists, pharmacologists, biotechnologists, and other allied professionals to discuss and present the latest important developments in their research.
 
The major topics of discussion related to drug design and discovery including: Cancer; Cardiovascular Diseases; CNS; Pharmacogenomics; Protein & Peptides; Inflammation & Allergy; Drug including Peptide, Gene and Vaccine Delivery; Drug Discovery Informatics; Drug Metabolism; Medicinal and Combinatorial Chemistry; Nanotechnology; Emerging Biomarkers & Drug Targets; Case Studies of Successful Drug Discovery and Development.
 
The conference highlight was the Nobel Laureates Day. Eleven Nobel Laureates (http://www.icddd.com/) were present and all gave lectures at the Higher College of Technology in Abu Dhabi. The lectures were not only scientific, but most of the Nobel Prize Winners spoke about their life journey.
 
The Chairman of the organizing committee was Nobel Laureate, Richard R. Ernst. Prof Istvan Toth was a member of the Scientific Advisory Board and was the Organizing Secretary of the very successful Drug Delivery Session. The University of Queensland (UQ) was represented by a big delegation including Professors Istvan Toth, Michael Roberts, Rodney Minchin, David Craik and Drs Jo Blanchfield and Pavla Simerska.
 
All of these participants gave invited presentations, thus representing the high quality science at UQ.
 

 
PhD Candidate Hoang Lam Pham Attends Asialink Dinner, Melbourne 
 
School of Pharmacy PhD candidate Hoang Lam Pham attended a gala Dinner on February 26th, to celebrate the 35th anniversary of the establishment of diplomatic relations between Vietnam and Australia.
 
The dinner was attended by His Excellency Dr Nguyen Thien Nhan, Deputy Prime Minister of Vietnam and Minister for Education and Training and the Hon Julia Gillard MP.
 
A UQ delegation led by Professor Trevor Grigg attended the event hosted by Asialink (University of Melbourne).
 
 
 
 
Included at the UQ table were 2 PhD scholars, including Hoang Lam Pham, a Pharmacy PhD candidate originally sponsored by MoET; Mr David Kennedy, Atlantic Philanthropies and Mr Hoang Ngoc Vinh, Deputy-General - Professional Education Dept, MoET. The two students were delighted to be personally introduced to the Deputy Prime Minister.
 
The keynote address by Professor Nguyen Thien Nhan outlined a vision for the development of Vietnam’s infrastructure and economy through a continued strong relationship with its regional neighbors, particularly Australia with its well-developed education system.
 
Current strong foreign investment - particularly in high technology industries in Vietnam - reflects Vietnam’s stable economy while presenting challenges in providing professionals and a high skilled workforce to meet the current demand and future anticipated growth to include labor export.
 
The main tasks for social and economic development were outlined in information circulated at the event. These tasks included priority points for education development.
 
Julia Gillard referred to Australia’s long standing commitment to Vietnam since 1974 and continuing aid under the Australian Government Scholarship program. She also encouraged overseas study for Australian students to Vietnam.
 

Dr Therese Kairuz - Senior Lecturer
Dr Therese Kairuz
 
Dr Therése Kairuz joined the School of Pharmacy as a Senior Lecturer in February 2008.
 
Dr Kairuz practiced in rural community pharmacy on a part-time basis after her registration with the South African Pharmacy council, and completed courses in supplementary prescribing.
 
She obtained a Master’s Degree (Pharmacy Practice) by distance education through Potchefstroom University before relocating to the city of Port Elizabeth. There she worked as a hospital pharmacist for two years before entering academia, and lectured introductory pharmaceutics and extemporaneous compounding at the University of Port Elizabeth (now the Nelson Mandela Metropolitan University), where she obtained her PhD.
 
In 2002 the family relocated to New Zealand where she was a founding member of the School of Pharmacy at The University of Auckland.
 
She lectured in the pharmacy practice division to second year students, and developed a research profile in various aspects of pharmacy practice.  She conducted the research of student and preceptor perceptions required for full accreditation of the School, and served on the Pre-registration Board of the New Zealand Pharmacy Council.  The family then moved to Brisbane where she lectured at the Queensland University of Technology before joining the University of Queensland.
 
 
Research Interests
 
Dr Kairuz’s research falls broadly into the theme of the Quality Use of Medicines.
 
Research subjects vary from pediatrics to the elderly, and research topics include drug utilization, compliance, user perceptions and extemporaneous medicines.
 
She would like to work with practicing pharmacists and professional organisations  to generate findings that will contribute to raising the profile of the pharmacy profession while also contributing to improved patient health outcomes.
 
 
 

About the School of Pharmacy Alumni Network Click to access to online registration form

When you graduate from the University of Queensland, you become part of a global network of some 150,000 graduates, or alumni. Every past student of the University is a valued member of the alumni community. The School of Pharmacy alumni network seeks to establish mutually beneficial links between graduates of the School, the University and the wider community. The School of Pharmacy Alumni network allows students to stay connected with the university and take an active role in the rich university life of UQ through social, educational and intellectual activities.

Some of the benefits of Alumni membership include:

  • Maintain valuable links with industry, allied health professionals, community organisations, fellow alumni and UQ
  • Networking with past students, staff and industry professionals through invitations to alumni functions, professional seminars and conferences
  • Opportunities for professional development through invitations to continuing education courses and lectures
  • Stay connected with your graduating class through reunions, social events, school newsletters and Graduate Connect magazine
  • Reduced rates for library access
  • Continued access to UQ Employment Services
  • Reduced rates for internet access via UQ Connect
  • Reduced rates for membership to UQ Sport
  • Membership to the UQ Staff and Graduates Club

The Alumni network is open to all graduates of The University of Queensland's School of Pharmacy. Associate membership is now being offered to current students as well. Membership is free, and you can request to leave the network at any time. To register for membership, please click on the button to the right.

Click to change your details online Please contact the School's Alumni Coordinator, Stephanie Dunn if you have any queries regarding The Alumni Network. If you are currently a member of the Alumni Network and wish to update your Address, contact numbers or email address please do so by clicking on the button to the left.

 


 
Planned Reunions - 2008

The Alumni Network plans to host 3 reunions in 2008. These will be:

  • 10 Year Reunion - Class of 1998
  • 20 Year Reunion - Class of 1988
  • 30 Year Reunion - Class of 1978
Other reunions may be held by special request, and in accordance with interest shown in the event.
For the 10, 20 and 30 year reunions that are planned, we will be looking for someone from each graduating class to assist in coordinating each event. The main duties of this person will be to help gather contact information for members of their class, liase with the School Alumni coordinator, answer email enquiries regarding the event, and help take RSVPs from attendees. Input on the proceedings of the event would also be called upon.

If you are a Graduate of any of the above classes, and would be interested in attending a reunion, or possibly assisting in the coordinating of the event, please contact the School Alumni Coordinator, Stephanie Dunn, on s.dunn@uq.edu.au or 07 3365 2034.


 
 
 
 
 
 

School of Pharmacy Graduate Heads Research Into New Addiction-Busting Drug

UQ pharmacy graduate Dr Selena Bartlett is starting clinical trials of a drug that could potentially curb addictions such as smoking, drinking, gambling even depression.

The drug, marketed as Chantix by Pfizer, has reduced alcohol consumption in laboratory rats by 50 percent and will be trialled in humans next month by Dr Bartlett and Dr Markus Heilig's team in the United States.

Chantix latches onto ‘good feeling' receptors in the brain to block cravings for addictions such as nicotine or alcohol.

Dr Bartlett is the Director of the Preclinical Development Group at the Ernest Gallo Clinic and Research Centre, one of the world's top alcohol and addiction research centres, at the University of California in San Francisco.

She said she was convinced of the drug's potential but it had been hard to convince others, despite the drug gaining widespread media attention in the US.

“Big companies still do not believe in the potential of addiction as a market, believe it or not,” Dr Bartlett said.

The Chantix trials are just one of 10 major projects for Dr Bartlett's lab team, which is working on reducing ethanol consumption and new drug screening technologies.

Dr Bartlett was asked to set up her preclinical lab to study addiction and how it modifies brain function.

“I wanted to make a difference in the world and develop treatments that would help people,” she said.

“Addiction is currently one of the most under-served and least understood.”

Her passion for understanding brain functions stemmed from her late-sister who had schizophrenia.

“She is still very much a driving force in my life and the reason I am doing this type of translational research.”

She also hopes to create a Foundation to fund research and develop better treatments for neuropsychiatric diseases such as schizophrenia, in memory of her sister.

Dr Bartlett grew up in the small South Burnett town of Nanango, where her parents ran the local pharmacy for 35 years — until last November.

She went to UQ like many of her siblings, parents and her husband's parents and grandparents going back to the 1920s.

She studied pharmacy at UQ with a Bachelor, Hons and PhD by 1994, with the expectation that she eventually work back in the family pharmacy.

By the time she finished her pharmacy study with a focus on morphine tolerance and dependence, she had also found two loves — her husband and neuroscience.

“I loved my time at UQ. It changed my life. I went in with all intentions of becoming a practising pharmacist and left a neuroscientist.

“I became addicted to the thrill of a new discovery and research . . .I also fell in love with neurosciences.

“I could see that understanding the neurobiological basis of addiction would provide valuable insights into brain function but also would help to uncover the causes of this devastating disease.”

Dr Bartlett and her husband Peter, also a UQ student at the time studying electrical engineering and computer science, met while windsurfing at the Gold Coast.

After working in Australia they moved to the US and then Dr Bartlett was offered the job of setting up a lab to develop a new model of translational research.

“I was advised not to do it. This is where being Australian and my early experiences in Nanango really kicked in. I decided to give it a go.”

She said growing up in a small country town and her time in the family's pharmacy gave her a pioneering attitude, fearlessness and stubbornness.

“I remember counting pills the old way, one by one, or ten by ten.

“I have vivid memories of my dad making ointments on a glass slab.

“My dad used to make industrial quantities of ointments at one time. The ointment was gooey and took forever to make, sometimes hours."

(Thank you to Mr Miguel Holland of UQ News for the use of this story)

Scholarships Awarded

Congratulations go to the following Scholarship Awardees:

  • Ms Neeraj Bala (PhD Candidate) - Australian Postgraduate Award
  • Ms Felicity Davis (PhD Candidate) - NHMRC Biomedical Postgraduate Scholarship
  • Mr Venkatesan Moorthy Rao (PhD Candidate) - School of Pharmacy International Living Allowance Scholarship
  • Mr Shafiur Rahman (PhD Candidate) - School of Pharmacy International Living Allowance Scholarship


Does Size Matter? - Pharmacy Research Team Investigates

School of Pharmacy PhD candidate, Phey Yen Han, along with Dr Bruce Green, Professor Stephen Duffull & Dr Carl Kirkpatrick are conducting a clinical trial into the influence of body size on drug clearance.

As the level of obesity in the Western World continues to rise dramatically, Dr Green said researchers faced the ongoing challenge of determining just how dosages should be adjusted to take body size and composition into account.

"In a pharmacological sense, obesity presents a challenging role for clinicians, as the effects of altered body composition on the time course of drug response are poorly understood," Dr Green said.

"[This] lack of dosing information... [is of additional concern when you] consider that many of these individuals require therapeutic intervention for a variety of disease states."

It is this lack of information that the School's Modelling and Simulation Group are looking to address as they work to optimise dosages for a variety of drugs in the overweight population.

PhD researcher Phey Yen Han says "Currently, dosing guidelines for the obese are inadequate, which we surmise has resulted from the exclusion of the obese from clinical trials."

"Given that alterations in body composition occur with obesity, a better understanding of the quantative relationship between body composition and drug clearance would significantly aid in improving dose adjustments for this population" she adds.

The team has recently had their research paper "Dosing in Obesity: A Simple Solution to a Big Problem" published in the Clinical Pharmacology & Therapeutics journal (Volume 82, Number 5), and Phey Yen Han plans on using the information gathered from their upcoming clinical trial for her PhD thesis.

The research group is now calling for male and female Caucasian non-smokers of a variety of weight ranges (45-200kg) to take part in their key study. Volunteers must be aged 18 years or above, have a body mass index of either 20-25kg/m2 or >30kg/m2, and be able to commit to the study across a 24-hour period. In particular, participants on the heavier end of the spectrum are required at this stage.

Participation will call for an initial visit to the Princess Alexandra Hospital for up to 7 hours, and a return visit the following morning for up to an hour.

For further information about the research or to volunteer for the study, contact Phey Yen Han on 07 3346 9718 or via email at phan@pharmacy.uq.edu.au or download more information in PDF format here.


The School of Pharmacy Welcomes the Following Research Higher Degree Candidates:

Commencing PhD Candidates:

  • Ms Neeraj Bala
  • Ms Felicity Davis
  • Ms Sharon Lin
  • Mr Venkatesan Moorthy Rao
  • Mr Shafiur Rahman

Commencing Postgraduate Honours Candidates:

  • Mr Sean Harris

 
 
Arrivals:

We are pleased to welcome the following staff to the School of Pharmacy:

  • Dr Alexandra (Zandy) Clavarino joined us in February in the position of Senior Lecturer
  • Ms Michele Dixon from the Faculty of Health Science has joined us in the role of Acting School Manager
  • Ms Katja Hjort has taken up a position as an Occupational Trainee working with Dr Carl Kirkpatrick
  • Dr Therese Kairuz joined us in February in the position of Senior Lecturer
  • Ms Rebecca Lee has joined the School as a Conjoint Associate Lecturer from Ipswich Hospital
  • Ms Catherine Lynch joined the School as a Conjoint Associate Lecturer from the Princess Alexandra Hospital
  • Ms Nimali Rahathungoda joined us in March as a Conjoint Associate Lecturer from the Princess Alexandra Hospital
  • Dr Santosh Rudrawar will be taking up a Postdoctoral Fellowship to work with Dr Ben Ross, Professor Nick Shaw & Dr Pete Cabot
  • Ms Heidi Wong, a Clinical Pharmacist with the Royal Children's Hospital has joined us as Conjoint Associate Lecturer

Farewells:

With our very best wishes we say farewell and thanks to the following staff:

  • Ms Christie Bentley, Scientific Officer, has finished in the School as of February
  • Dr Nigel Davies has left the School after many years. We wish him all the best for the future
  • Ms Bis Parry has left the School as of March. We would like to wish Bis all the best for the future and thank her for her work as School Manager
  • Dr Samantha South from TetraQ has left the School as of February
  • Mr Garry Walker has left the School as of February

>> back to top


Please send all contributions for the School of Pharmacy Bulletin to Ms Stephanie dunn, at news@pharmacy.uq.edu.au